Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Ustekinumab, (Obg) Atc L04Ac05 For The Period 01.03.2025 - 28.02.2027

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 101639203

  Document Type - Tender Notices

Description - Description: Section 130a paragraph 8 of the Social Code Book V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the drugs dispensed at the expense of the statutory health insurance compani es. In view of the relevant legal provisions for the award of public contracts, a regular process of active substance-related, formal award procedures takes place by DAK-Gesundheit in accordance with the regulations of Part 4 of the GWB. For drugs containing the above-mentioned active substance, ustekinumab, ATC L04AC05, which are to be specified by the bidder in Annex 2 to the contract, DAK-Gesundheit intends to conclude drug discount agreements

Gt Ref Id - 101639203

Deadline - Jan 05, 2027